NCT01706263 - U0289-402: An Open Label, 8 Week Study to Evaluate the Efficacy and Tolerability of MAXCLARITY II in Subjects With Acne | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 1, 2009

Primary Completion Date

November 20, 2009

Study Completion Date

November 20, 2009

Conditions

Acne Vulgaris

Interventions

DRUG

MAXCLARITY II (2.5% BPO) Foam Cleanser

Available over the counter.

DRUG

MAXCLARITY II (2.5% BPO) Foam Treatment

Available over the counter.

DRUG

MAXCLARITY II (0.5% Salicylic Acid) Toner Foam

Available over the counter.